Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis (clinicaltrials.gov) - Aug 5, 2026 - P1 | N=10 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Anhui Medical University
New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
|